Ritedose Partners with Newberry College for Innovative Program
In response to the rising demand for skilled professionals in the life science industry, Ritedose has joined forces with Newberry College to create an exciting new Pharmaceutical Manufacturing program. This initiative aims to bridge the gap between education and the evolving needs of the workforce.
Program Overview and Objectives
The collaboration is set to prepare students for successful careers in the pharmaceutical manufacturing sector. The program is designed to address the increasing need for a highly qualified workforce in a rapidly expanding field. Ritedose, being a leader in pharmaceutical manufacturing, brings invaluable industry insights and expertise to this partnership.
Curriculum and Course Structure
The Pharmaceutical Manufacturing program will be a comprehensive 30-hour bachelor's degree tailored for students who already hold associate degrees. With a focus on quality, compliance, and optimization processes, this program will include ten asynchronous courses that ensure flexibility and accessibility for students balancing work and study.
Real-World Applications and Industry Standards
The courses, developed by Ritedose’s team of industry professionals, will cover essential topics like "Sterile Procedures" and "FDA Guidelines for Pharmaceutical Manufacturers." This hands-on approach is designed to equip students with a thorough understanding of the key issues and regulations facing the pharmaceutical sector today.
Benefits of the Partnership
Bob Sikora, Senior Director of Quality Assurance at Ritedose, expressed excitement about the collaboration, stating, "This partnership exemplifies a forward-thinking approach to education and workforce development. By integrating our practical industry experience with Newberry College's academic resources, we provide students with the skills necessary to excel in the pharmaceutical manufacturing landscape."
Driving Innovation in South Carolina
The partnership not only focuses on education but also aims to position South Carolina as a leader in pharmaceutical manufacturing innovation. Tracy Cook, Director of Health Sciences at Newberry College, highlighted, "This collaboration allows us to meet industry needs while offering a unique educational experience, paving the way for our students to enter an important market successfully."
About Ritedose
Ritedose is recognized as the largest Contract Development and Manufacturing Organization (CDMO) in the United States, specializing in sterile Blow Fill Seal (BFS) production for unit dose solutions targeted at the ophthalmic and respiratory markets. With a steadfast commitment to quality and customer satisfaction, Ritedose collaborates with leading pharmaceutical companies to provide safe and effective medications that significantly enhance patient outcomes.
About Newberry College
Newberry College is a private institution known for its diverse student body and commitment to liberal arts education. Established in 1856, it has consistently been ranked among the top colleges in the South and offers a wide range of academic programs, ensuring that students receive a comprehensive education that prepares them for future success.
Frequently Asked Questions
What is the goal of the Ritedose and Newberry College partnership?
The partnership aims to launch a Pharmaceutical Manufacturing program to equip students with skills for the growing life sciences industry.
Who will benefit from the Pharmaceutical Manufacturing program?
This program is designed for students with associate degrees looking to advance their education and career in pharmaceutical manufacturing.
What topics will the program cover?
Courses will include subjects like sterile procedures and FDA guidelines, focusing on compliance and quality in pharmaceutical manufacturing.
Is the program available online?
Yes, the program will be offered asynchronously, allowing students to learn at their own pace.
What is Ritedose's role in the program?
Ritedose provides industry expertise and helps shape the curriculum, ensuring it meets the real-world demands of the pharmaceutical sector.
